» Authors » Paola Stefanoni

Paola Stefanoni

Explore the profile of Paola Stefanoni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 55
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Martino E, Derudas D, Rossi E, Stefanoni P, Mangiacavalli S, Zamagni E, et al.
Hematol Oncol . 2025 Feb; 43(2):e70042. PMID: 39898517
This multicenter real-world analysis evaluated the efficacy of isatuximab, pomalidomide, and dexamethasone (IsaPd) in 51 patients with multiple myeloma (MM) who were refractory to daratumumab (Dara-R). The majority were under...
3.
4.
Stefanoni P, Paris L, Pittalis N, Pavoni C, Cavallaro G, Rambaldi A, et al.
Mediterr J Hematol Infect Dis . 2024 Sep; 16(1):e2024066. PMID: 39258181
No abstract available.
5.
6.
DAgostino M, Rota-Scalabrini D, Belotti A, Bertamini L, Arigoni M, De Sabbata G, et al.
Blood Cancer J . 2024 Jun; 14(1):94. PMID: 38849344
Additional copies of chromosome 1 long arm (1q) are frequently found in multiple myeloma (MM) and predict high-risk disease. Available data suggest a different outcome and biology of patients with...
7.
Autore F, Bramanti S, Lessi F, Innocenti I, Galli E, Rocchi S, et al.
Haematologica . 2023 Aug; 109(3):888-894. PMID: 37646655
Autologous peripheral blood stem cell transplantation (aPBSCT) provides optimal outcomes in POEMS syndrome but the definition of the best treatment before aPBSCT remains to be defined because of the rarity...
8.
Perego G, Paris L, Nozza S, Stefanoni P, Franzin M
J Oncol Pharm Pract . 2023 May; 29(5):1234-1236. PMID: 37186789
No abstract available.
9.
Pompa A, Pettine L, Giannarelli D, Paris L, Torretta L, Cavallaro F, et al.
Eur J Haematol . 2021 Jul; 107(5):566-572. PMID: 34297879
Objectives: Autologous stem cell transplantation is the gold standard for eligible newly diagnosed multiple myeloma patients. Patients are usually hospitalized for administration of mobilization chemotherapy. We aimed to assess safety...
10.
Salmoiraghi S, Cavagna R, Zanghi P, Pavoni C, Michelato A, Buklijas K, et al.
Cancers (Basel) . 2020 Aug; 12(8). PMID: 32796597
By way of a Next-Generation Sequencing NGS high throughput approach, we defined the mutational profile in a cohort of 221 normal karyotype acute myeloid leukemia (NK-AML) enrolled into a prospective...